Abstract
Abstract Class III medical devices are those devices that support or sustain human life or prevent impairment of human health but, when used, pose high risks to the patients. There were 15 class III medical devices that were approved by the US Food and Drug Administration from September 1, 2005 to December 31, 2018 for glucose monitoring and diabetes treatment. In this article, we reviewed the study design and statistical analysis in clinical trials that were conducted to provide evidences for safety and effectiveness of these medical devices. Two exemplars of clinical trials for “Eversense continuous glucose monitoring system” and “t:slim X2 Insulin Pump with Basal-IQ Technology” are discussed in details.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
